Barrett'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Barrett's esophagus diagnosed by endoscopy
Exclusion criteria
Exclusion criteria: (1)Patients with malignancy in other organs (2)Patients with having allergy to PPIs or drugs used for H. pylori eradication (3)Patients who are regularly taking PPIs or non-steroidal anti-inflammatory drugs (4)Past episode of H. pylori treatment (5)Patients with having a past history of esophagectomy or gastrectomy (6)Patients who have determined by the physicians to have any reasons of unqualified
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes of biomarkers related to pathogenesis of Barrett's esophagus are evaluated at baseline and 1-yr after intervention with/without PPI administration in H. pylori negative patients and H. pylori eradication in H. pylori positive patients | — |
Countries
Japan
Contacts
Hyogo College of Medicine Division of Gastroenterology, Department of Internal Medicine